§ 17. Helen JacksonTo ask the Secretary of State for Health if he will make a statement on the NICE report on the availability of beta interferon for MS sufferers. [3780]
§ Mr. HuttonThe National Institute for Clinical Excellence's Appraisal Committee is carefully considering the extensive comments on the Provisional Appraisal Determination. NICE expects to issue its guidance by December 2001.
§ 31. Bob SpinkTo ask the Secretary of State for Health what assessment his Department has made of the clinical benefits of beta interferon for MS sufferers. [3794]
§ Mr. HuttonIn view of the uncertainty over the appropriate use of beta interferon, we asked the National Institute for Clinical Excellence to conduct an authoritative appraisal on the evidence of beta interferon and glatiramer acetate. NICE expects to issue its guidance by December 2001.